Cash · 2011–2025
Adma Biologics cash
$87.6M−15.0% · FY2025
Adma Biologics (ADMA) reported $87.6M in cash for fiscal 2025, −15.0% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $87.6M | −15.0% | Open → |
| FY20242024-12-31 | $103M | +100.9% | Open → |
| FY20232023-12-31 | $51.4M | −40.6% | Open → |
| FY20222022-12-31 | $86.5M | +69.4% | Open → |
| FY20212021-12-31 | $51.1M | −8.6% | Open → |
| FY20202020-12-31 | $55.9M | +109.0% | Open → |
| FY20192019-12-31 | $26.8M | −0.0% | Open → |
| FY20182018-12-31 | $26.8M | −37.9% | Open → |
| FY20172017-12-31 | $43.1M | +334.8% | Open → |
| FY20162016-12-31 | $9.9M | −5.0% | Open → |
| FY20152015-12-31 | $10.4M | −39.3% | Open → |
| FY20142014-12-31 | $17.2M | −34.2% | Open → |
| FY20132013-12-31 | $26.1M | +108.6% | Open → |
| FY20122012-12-31 | $12.5M | +14,182.2% | Open → |
| FY20112011-12-31 | $87,771 | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +63.8%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Adma Biologics cash |url=https://companiesranked.com/en/company/adma-biologics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Adma Biologics cash. CompaniesRanked. https://companiesranked.com/en/company/adma-biologics/cash-on-handBibTeX
@misc{companiesranked-en-company-adma-biologics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Adma Biologics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/adma-biologics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001140361-26-031445 · August 5, 2026
{{cite web |title=Adma Biologics cash — 10-Q (0001140361-26-031445) |url=https://www.sec.gov/Archives/edgar/data/1368514/000114036126031445/ef20075111_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.